Kim Sanghyun, Kim Changsoo, Choi Yoon Jung
Department of Public Health, The Graduate School of Yonsei University, Seoul, Korea.
Review and Assessment Research Department, Health Insurance Review and Assessment Service, Wonju, Korea.
Yonsei Med J. 2025 Sep;66(9):590-598. doi: 10.3349/ymj.2024.0303.
Alzheimer's disease (AD) is the leading cause of dementia and is associated with various socioeconomic factors. This study aimed to ascertain the differences in AD prevalence based on healthcare coverage type as a proxy of socioeconomic status in South Korea.
We examined Health Insurance Review and Assessment Service claims from 2010-2019, identifying AD as the main disease. Crude prevalence rate and age- and sex-standardized prevalence were estimated from healthcare utilization data. Subgroup analysis by age, sex, comorbidities (hypertension, diabetes, and cardiovascular disease), and type of healthcare coverage [Medical Aid (MA) vs. National Health Insurance (NHI)] was performed to estimate the standardized prevalence rate ratio (PRR).
AD prevalence increased 3.9 times from 2010 (175688 cases) to 2019 (680800 cases). In the NHI group, the standardized prevalence increased 2.3-fold (624.4 in 2010 and 1433.2 in 2019), whereas the MA group saw a 2.7-fold increase (1251.0 in 2010 and 3391.9 in 2019). AD was significantly higher in the MA group from 2010 [PRR=2.00, 95% confidence interval (CI) 1.98-2.03] to 2019 (PRR=2.37, 95% CI 2.35-2.38) compared to the NHI group. From 2010 to 2019, a proportion of comorbidities increased in MA and NHI groups. Compared to the NHI group, the MA group showed significantly higher proportion of comorbidities.
In this study, we identified significant differences in AD prevalence between NHI and MA recipients, with a notable increase in the MA group, especially among those under 60 years of age.
阿尔茨海默病(AD)是痴呆的主要病因,且与多种社会经济因素相关。本研究旨在确定基于医疗覆盖类型(作为韩国社会经济地位的替代指标)的AD患病率差异。
我们检查了2010年至2019年健康保险审查与评估服务机构的理赔数据,将AD确定为主要疾病。根据医疗利用数据估算粗患病率以及年龄和性别标准化患病率。按年龄、性别、合并症(高血压、糖尿病和心血管疾病)以及医疗覆盖类型[医疗救助(MA)与国民健康保险(NHI)]进行亚组分析,以估算标准化患病率比(PRR)。
AD患病率从2010年的175688例增至2019年的680800例,增长了3.9倍。在NHI组中,标准化患病率增长了2.3倍(2010年为624.4,2019年为1433.2),而MA组增长了2.7倍(2010年为1251.0,2019年为3391.9)。与NHI组相比,2010年至2019年期间,MA组的AD患病率显著更高[PRR = 2.00,95%置信区间(CI)1.98 - 2.03]至2019年(PRR = 2.37,95% CI 2.35 - 2.38)。2010年至2019年,MA组和NHI组合并症的比例均有所增加。与NHI组相比,MA组合并症的比例显著更高。
在本研究中,我们发现NHI和MA接受者之间的AD患病率存在显著差异,MA组显著增加,尤其是在60岁以下人群中。